Lv51
1170 积分 2025-03-16 加入
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
56分钟前
求助中
Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the Blood
5小时前
已关闭
Factor D
11小时前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
1个月前
已完结
Metabolism of New Drug Modalities Research Advances – 2024 year in review
2个月前
已完结
De Novo Discovery of a Macrocyclic Peptide Antagonist of Interleukin-11 with Antirenal Fibrotic Efficacy
2个月前
已完结
Discovery and development of bispecific antibodies
3个月前
已完结
Quantification of Proteolytically Active Pregnancy-Associated Plasma Protein-A with an Assay Based on Quenched Fluorescence
3个月前
已完结
Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing
4个月前
已完结
Multi-ancestry genome-wide association analyses of polycystic ovary syndrome
2个月前
已采纳
The endocrine complications of cystic fibrosis
2个月前
已采纳
The complexity of the relationship between thyroid disease and body weight
2个月前
已采纳
The complexity of the relationship between thyroid disease and body weight
2个月前
已采纳
The complexity of the relationship between thyroid disease and body weight
2个月前
已采纳
Using DNA nanotubes to grow cytoskeletons in DNA-based synthetic cells
2个月前
已采纳
Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway
2个月前
已采纳
Phase III trial of telitacicept in SLE
2个月前
已采纳
Phase III trial of telitacicept in SLE
2个月前
已采纳
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector function
4个月前
已采纳
皖公网安备34019202002308
